0000899243-18-006551.txt : 20180306
0000899243-18-006551.hdr.sgml : 20180306
20180306202752
ACCESSION NUMBER: 0000899243-18-006551
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20180302
FILED AS OF DATE: 20180306
DATE AS OF CHANGE: 20180306
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Malik Rajiv
CENTRAL INDEX KEY: 0001388111
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 333-199861
FILM NUMBER: 18671671
MAIL ADDRESS:
STREET 1: 1500 CORPORATE DRIVE, SUITE 400
CITY: CANONSBURG
STATE: PA
ZIP: 15317
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Mylan N.V.
CENTRAL INDEX KEY: 0001623613
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 981189497
STATE OF INCORPORATION: P7
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: BUILDING 4, TRIDENT PLACE, MOSQUITO WAY
CITY: HATFIELD, HERTFORDSHIRE
STATE: X0
ZIP: AL10 9UL
BUSINESS PHONE: 44 0 1707 853 000
MAIL ADDRESS:
STREET 1: BUILDING 4, TRIDENT PLACE, MOSQUITO WAY
CITY: HATFIELD, HERTFORDSHIRE
STATE: X0
ZIP: AL10 9UL
FORMER COMPANY:
FORMER CONFORMED NAME: New Moon B.V.
DATE OF NAME CHANGE: 20141028
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2018-03-02
0
0001623613
Mylan N.V.
MYL
0001388111
Malik Rajiv
BUILDING 4, TRIDENT PLACE, MOSQUITO WAY
HATFIELD, HERTFORDSHIRE
X0
AL10 9UL
UNITED KINGDOM
1
1
0
0
President
Ordinary Shares
2018-03-02
4
S
0
50000
40.9139
D
503751
D
Ordinary Shares
2018-03-03
4
M
0
12395
0.00
A
516146
D
Ordinary Shares
2018-03-03
4
F
0
5472
40.97
D
510674
D
Ordinary Shares
2018-03-04
4
M
0
5264
0.00
A
515938
D
Ordinary Shares
2018-03-04
4
F
0
2324
40.97
D
513614
D
Ordinary Shares
2018-03-04
4
M
0
35532
0.00
A
549146
D
Ordinary Shares
2018-03-04
4
F
0
14977
40.97
D
534169
D
Ordinary Shares
250000
I
By Grantor Retained Annuity Trust
Employee Stock Option - Right to Buy
40.97
2018-03-02
4
A
0
71600
0.00
A
2028-03-02
Ordinary Shares
71600
71600
D
Restricted Stock Units
0.00
2018-03-02
4
A
0
43935
0.00
A
Ordinary Shares
43935
43935
D
Restricted Stock Units
0.00
2018-03-03
4
M
0
12395
0.00
D
Ordinary Shares
12395
24790
D
Restricted Stock Units
0.00
2018-03-04
4
M
0
5264
0.00
D
Ordinary Shares
5264
0
D
Performance Restricted Stock Units
0.00
2018-03-04
4
M
0
35532
0.00
D
Ordinary Shares
35532
0
D
Represents the weighted average price of the reporting person's disposition of 50,000 shares in transactions ranging from $40.78 to $41.13. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of ordinary shares sold at each separate price within the range set forth in this footnote.
Represents withholding of ordinary shares for the tax liability associated with the vesting and settlement of a portion of the restricted stock units (RSUs) granted on March 3, 2017.
Represents withholding of ordinary shares for the tax liability associated with the vesting and settlement of a portion of the RSUs granted on November 17, 2015.
Represents withholding of ordinary shares for the tax liability associated with the vesting and settlement of the performance restricted stock units (PRSUs) granted on November 17, 2015.
23,867 of the options will vest on March 2, 2019, 23,866 will vest on March 2, 2020, and 23,867 will vest on March 2, 2021. The options expire on March 2, 2028.
Each RSU represents the right to receive one ordinary share of Mylan N.V. The RSUs vest in three equal annual installments beginning on March 2, 2019.
Each RSU represents the right to receive one ordinary share of Mylan N.V. 12,395 of the RSUs granted on March 3, 2017 vested on March 3, 2018, and 12,395 will vest on each of March 3, 2019 and March 3, 2020.
Each RSU represents the right to receive one ordinary share of Mylan N.V. 5,264 of the RSUs granted on November 17, 2015 vested on each of March 4, 2016, March 4, 2017, and March 4, 2018.
Each PRSU represents the right to receive one ordinary share of Mylan N.V. The PRSUs were initially granted on November 17, 2015, subject to the attainment of previously established two-year performance goals and a vesting period. The PRSUs fully vested on March 4, 2018.
/s/ Kevin Macikowski, by power of attorney
2018-03-06